- Adams Respiratory and Mutual Pharma settle guaifenesin patent litigation: press release
- FTC subpoenas Cephalon over Provigil patent litigation settlements: AP; Phil. Bus. J.
- Glenmark first to file Zetia ANDA with paragraph IV certification: Bloomberg
- Senate holds hearing on pediatric exclusivity: Reuters
- Takeda awarded $16.8 million in fees in pioglitazone patent case: NY Law J.; Reuters
Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Orange Book Blog 
Leave a comment